# ARS Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Aug 1, 2025

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: SCHEDULE 13D/A
- Filed: 2025-08-01
- Accepted by EDGAR: Aug 1, 2025, 18:06 ET
- Period: not reported
- Accession: 0001193805-25-001146
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119380525001146/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119380525001146/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119380525001146/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Aug 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001193805-25-001146. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.
